Alex Yi

Alex Yi, MD, PhD


Alex Yi, M.D Ph.D, is the VP of Clinical Development at Bitterroot Bio.

Dr. Yi has more than 10 years of industry experience in early and late phase clinical development programs in the cardiovascular, metabolic, and rare disease therapeutic areas. Dr. Yi previously worked in clinical development and translational medicine at Anthos Therapeutics, Vertex Pharmaceuticals, and the Novartis Institutes for BioMedical Research.

Dr. Yi received an M.D and Ph.D in Neuroscience at the University of California, San Francisco. He completed his training in Internal Medicine at NY Presbyterian Hospital/Weill Cornell Medical College and fellowship in cardiovascular diseases at Massachusetts General Hospital.

Bitterroot Bio is a privately held company dedicated to the pursuit of breakthroughs in cardiovascular medicine. We are committed to improving the lives of patients, and we believe that focusing on research and development is the best way to achieve that goal. We do not engage in, support, or advocate on behalf of political, social, environmental, or other causes that are unrelated to our mission.
Scroll to Top